Viewing Study NCT00140556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2026-02-20 @ 8:08 PM
Study NCT ID: NCT00140556
Status: COMPLETED
Last Update Posted: 2013-01-18
First Post: 2005-08-29
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Sponsor: David M. Brizel, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
None Pharynx Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None head and neck cancer View
None targeted therapy View
None bevacizumab View
None erlotinib View
None Tarceva View
None radiotherapy View
None concurrent chemotherapy View
None pharynx cancer View
None tonsil cancer View
None hyperfractionation View
None angiogenesis View
None epidermal growth factor View
None vascular endothelial growth factor View
None magnetic resonance spectroscopy View
None cancer of the head and neck View
None upper aerodigestive tract neoplasms View
None pharynx neoplasms View